|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Choi S and Myers JN: Molecular
pathogenesis of oral squamous cell carcinoma: Implications for
therapy. J Dent Res. 87:14–32. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hunter KD, Parkinson EK and Harrison PR:
Profiling early head and neck cancer. Nat Rev Cancer. 5:127–135.
2005. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang YJ, Zhang ZF, Fan SH, Zhuang J, Shan
Q, Han XR, Wen X, Li MQ, Hu B, Sun CH, et al: MicroRNA-433 inhibits
oral squamous cell carcinoma cells by targeting FAK. Oncotarget.
8:100227–100241. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bonner JA, Harari PM, Giralt J, Cohen RB,
Jones CU, Sur RK, Raben D, Baselga J, Spencer SA, Zhu J, et al:
Radiotherapy plus cetuximab for locoregionally advanced head and
neck cancer: 5-year survival data from a phase 3 randomised trial,
and relation between cetuximab-induced rash and survival. Lancet
Oncol. 11:21–28. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chia WJ and Tang BL: Emerging roles for
Rab family GTPases in human cancer. Biochim Biophys Acta.
1795:110–116. 2009.PubMed/NCBI
|
|
7
|
Recchi C and Seabra MC: Novel functions
for Rab GTPases in multiple aspects of tumour progression. Biochem
Soc Trans. 40:1398–1403. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen D, Guo J, Miki T, Tachibana M and
Gahl WA: Molecular cloning of two novel rab genes from human
melanocytes. Gene. 174:129–134. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Klopper TH, Kienle N, Fasshauer D and
Munro S: Untangling the evolution of Rab G proteins: Implications
of a comprehensive genomic analysis. BMC Biol. 10:712012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ng EL, Wang Y and Tang BL: Rab22B's role
in trans-Golgi network membrane dynamics. Biochem Biophys Res
Commun. 361:751–757. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Abba MC, Hu Y, Sun H, Drake JA, Gaddis S,
Baggerly K, Sahin A and Aldaz CM: Gene expression signature of
estrogen receptor alpha status in breast cancer. BMC Genomics.
6:372005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Grismayer B, Solch S, Seubert B, Kirchner
T, Schäfer S, Baretton G, Schmitt M, Luther T, Krüger A, Kotzsch M
and Magdolen V: Rab31 expression levels modulate tumor-relevant
characteristics of breast cancer cells. Mol Cancer. 11:622012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pu SY, Yu Q, Wu H, Jiang JJ, Chen XQ, He
YH and Kong QP: ERCC6L, a DNA helicase, is involved in cell
proliferation and associated with survival and progress in breast
and kidney cancers. Oncotarget. 8:42116–42124. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Amornphimoltham P, Rechache K, Thompson J,
Masedunskas A, Leelahavanichkul K, Patel V, Molinolo A, Gutkind JS
and Weigert R: Rab25 regulates invasion and metastasis in head and
neck cancer. Clin Cancer Res. 19:1375–1388. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Clausen MJ, Melchers LJ, Mastik MF,
Slagter-Menkema L, Groen HJ, Laan BF, van Criekinge W, de Meyer T,
Denil S, van der Vegt B, et al: RAB25 expression is epigenetically
downregulated in oral and oropharyngeal squamous cell carcinoma
with lymph node metastasis. Epigenetics. 11:653–663. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang D, Lu C and Ai H: Rab5a is
overexpressed in oral cancer and promotes invasion through ERK/MMP
signaling. Mol Med Rep. 16:4569–4576. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bao Q, Liao X, Li R and Ding N: KCNQ1OT1
promotes migration and inhibits apoptosis by modulating
miR-185-5p/Rab14 axis in oral squamous cell carcinoma. Dev Growth
Differ. 61:466–474. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhu Y, Shi F, Wang M and Ding J: Knockdown
of Rab9 suppresses the progression of gastric cancer through
regulation of Akt signaling pathway. Technol Cancer Res Treat.
19:15330338209159582020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pollaers K, Hinton-Bayre A, Friedland PL
and Farah CS: AJCC 8th Edition oral cavity squamous cell carcinoma
staging-Is it an improvement on the AJCC 7th Edition? Oral Oncol.
82:23–28. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang H, Bao W, Jiang F, Che Q, Chen Z,
Wang F, Tong H, Dai C, He X, Liao Y, et al: Mutant p53 (p53-R248Q)
functions as an oncogene in promoting endometrial cancer by
up-regulating REGγ. Cancer Lett. 360:269–279. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chua CE and Tang BL: The role of the small
GTPase Rab31 in cancer. J Cell Mol Med. 19:1–10. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pan Y, Zhang Y, Chen L, Liu Y, Feng Y and
Yan J: The Critical Role of Rab31 in cell proliferation and
apoptosis in cancer progression. Mol Neurobiol. 53:4431–4437. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sui Y, Zheng X and Zhao D: Rab31 promoted
hepatocellular carcinoma (HCC) progression via inhibition of cell
apoptosis induced by PI3K/AKT/Bcl-2/BAX pathway. Tumour Biol.
36:8661–8670. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kotzsch M, Kirchner T, Soelch S, Friedrich
K, Baretton G, Magdolen V and Luther T: Inverse association of
rab31 and mucin-1 (CA15-3) antigen levels in estrogen
receptor-positive (ER+) breast cancer tissues with
clinicopathological parameters and patients' prognosis. Am J Cancer
Res. 7:1959–1970. 2017.PubMed/NCBI
|
|
26
|
Zhang P, Zhang Z, Zhou X, Qiu W, Chen F
and Chen W: Identification of genes associated with cisplatin
resistance in human oral squamous cell carcinoma cell line. BMC
Cancer. 6:2242006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zheng G, Zhou M, Ou X, Peng B, Yu Y, Kong
F, Ouyang Y and He Z: Identification of carbonic anhydrase 9 as a
contributor to pingyangmycin-induced drug resistance in human
tongue cancer cells. FEBS J. 277:4506–4518. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kotzsch M, Sieuwerts AM, Grosser M, Meye
A, Fuessel S, Meijer-van Gelder ME, Smid M, Schmitt M, Baretton G,
Luther T, et al: Urokinase receptor splice variant
uPAR-del4/5-associated gene expression in breast cancer:
Identification of rab31 as an independent prognostic factor. Breast
Cancer Res Treat. 111:229–240. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kotzsch M, Dorn J, Doetzer K, Schmalfeldt
B, Krol J, Baretton G, Kiechle M, Schmitt M and Magdolen V: mRNA
expression levels of the biological factors uPAR, uPAR-del4/5, and
rab31, displaying prognostic value in breast cancer, are not
clinically relevant in advanced ovarian cancer. Biol Chem.
392:1047–1051. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li Z, Cui J, Yu Q, Wu X, Pan A and Li L:
Evaluation of CCND1 amplification and CyclinD1 expression: diffuse
and strong staining of CyclinD1 could have same predictive roles as
CCND1 amplification in ER positive breast cancers. Am J Transl Res.
8:142–153. 2016.PubMed/NCBI
|
|
31
|
Zhang W, Liu Y, Li YF, Yue Y, Yang X and
Peng L: Targeting of survivin pathways by YM155 inhibits cell death
and invasion in oral squamous cell carcinoma cells. Cell Physiol
Biochem. 38:2426–2437. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang J, Kong R and Sun L: Silencing of
Rab3D suppresses the proliferation and invasion of esophageal
squamous cell carcinoma cells. Biomed Pharmacother. 91:402–407.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Henriques AC, de Matos FR, Galvao HC and
Freitas Rde A: Immunohistochemical expression of MMP-9 and VEGF in
squamous cell carcinoma of the tongue. J Oral Sci. 54:105–111.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Heikkila P, Suojanen J, Pirila E, Väänänen
A, Koivunen E, Sorsa T and Salo T: Human tongue carcinoma growth is
inhibited by selective antigelatinolytic peptides. Int J Cancer.
118:2202–2209. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bobrie A, Krumeich S, Reyal F, Recchi C,
Moita LF, Seabra MC, Ostrowski M and Théry C: Rab27a supports
exosome-dependent and -independent mechanisms that modify the tumor
microenvironment and can promote tumor progression. Cancer Res.
72:4920–4930. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Stephens DC, Osunsanmi N, Sochacki KA,
Powell TW, Taraska JW and Harris DA: Spatiotemporal organization
and protein dynamics involved in regulated exocytosis of MMP-9 in
breast cancer cells. J Gen Physiol. 151:1386–1403. 2019. View Article : Google Scholar : PubMed/NCBI
|
